Logo image of CREX

CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CREX - US22530J3095 - Common Stock

2.83 USD
-0.01 (-0.35%)
Last: 12/12/2025, 8:22:56 PM
Fundamental Rating

3

CREX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 95 industry peers in the Media industry. CREX may be in some trouble as it scores bad on both profitability and health. CREX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CREX was profitable.
CREX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.94%, CREX is in line with its industry, outperforming 49.47% of the companies in the same industry.
CREX's Return On Equity of -4.19% is in line compared to the rest of the industry. CREX outperforms 53.68% of its industry peers.
Industry RankSector Rank
ROA -1.94%
ROE -4.19%
ROIC N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Gross Margin of CREX (43.41%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CREX has grown nicely.
The Profit Margin and Operating Margin are not available for CREX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CREX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CREX has more shares outstanding
Compared to 5 years ago, CREX has more shares outstanding
Compared to 1 year ago, CREX has a worse debt to assets ratio.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -0.02, we must say that CREX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.02, CREX is not doing good in the industry: 68.42% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.68 indicates that CREX is somewhat dependend on debt financing.
The Debt to Equity ratio of CREX (0.68) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z -0.02
ROIC/WACCN/A
WACC7.26%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.01 indicates that CREX should not have too much problems paying its short term obligations.
CREX's Current ratio of 1.01 is in line compared to the rest of the industry. CREX outperforms 41.05% of its industry peers.
A Quick Ratio of 0.93 indicates that CREX may have some problems paying its short term obligations.
CREX has a worse Quick ratio (0.93) than 61.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 0.93
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

6

3. Growth

3.1 Past

CREX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
Looking at the last year, CREX shows a quite strong growth in Revenue. The Revenue has grown by 12.59% in the last year.
Measured over the past years, CREX shows a quite strong growth in Revenue. The Revenue has been growing by 9.98% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%

3.2 Future

The Earnings Per Share is expected to grow by 50.60% on average over the next years. This is a very strong growth
Based on estimates for the next years, CREX will show a very strong growth in Revenue. The Revenue will grow by 32.68% on average per year.
EPS Next Y131.68%
EPS Next 2Y50.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.13%
Revenue Next 2Y11.12%
Revenue Next 3Y32.68%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.21, CREX is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of CREX indicates a somewhat cheap valuation: CREX is cheaper than 71.58% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.56. CREX is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 32.01 indicates a quite expensive valuation of CREX.
CREX's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of CREX to the average of the S&P500 Index (23.79), we can say CREX is valued slightly more expensively.
Industry RankSector Rank
PE 20.21
Fwd PE 32.01
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CREX's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.8
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

CREX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CREX's earnings are expected to grow with 50.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)N/A
EPS Next 2Y50.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CREX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CREATIVE REALITIES INC

NASDAQ:CREX (12/12/2025, 8:22:56 PM)

2.83

-0.01 (-0.35%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-12 2026-03-12/bmo
Inst Owners15.19%
Inst Owner Change-23.71%
Ins Owners17.24%
Ins Owner Change21.85%
Market Cap29.77M
Revenue(TTM)50.85M
Net Income(TTM)-1.23M
Analysts84
Price Target8.29 (192.93%)
Short Float %0.89%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)225.73%
Min EPS beat(2)-149.99%
Max EPS beat(2)601.45%
EPS beat(4)2
Avg EPS beat(4)117.54%
Min EPS beat(4)-149.99%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.64%
Min Revenue beat(2)-11.52%
Max Revenue beat(2)6.23%
Revenue beat(4)3
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)6.23%
Revenue beat(8)4
Avg Revenue beat(8)-1.96%
Revenue beat(12)4
Avg Revenue beat(12)-3.57%
Revenue beat(16)4
Avg Revenue beat(16)-3.18%
PT rev (1m)14.04%
PT rev (3m)22.64%
EPS NQ rev (1m)-48.28%
EPS NQ rev (3m)-89.69%
EPS NY rev (1m)0%
EPS NY rev (3m)-29.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.03%
Valuation
Industry RankSector Rank
PE 20.21
Fwd PE 32.01
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 1.01
P/tB N/A
EV/EBITDA 15.8
EPS(TTM)0.14
EY4.95%
EPS(NY)0.09
Fwd EY3.12%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS4.58
BVpS2.8
TBVpS-1.78
PEG (NY)0.15
PEG (5Y)N/A
Graham Number2.97
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -4.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.41%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score3
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 6.52
Cap/Depr 54.53%
Cap/Sales 5.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.01
Quick Ratio 0.93
Altman-Z -0.02
F-Score3
WACC7.26%
ROIC/WACCN/A
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2100%
EPS Next Y131.68%
EPS Next 2Y50.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-26.97%
Revenue Next Year-1.13%
Revenue Next 2Y11.12%
Revenue Next 3Y32.68%
Revenue Next 5YN/A
EBIT growth 1Y-161.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year580.51%
EBIT Next 3Y202.07%
EBIT Next 5YN/A
FCF growth 1Y-268.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.91%
OCF growth 3Y93.04%
OCF growth 5YN/A

CREATIVE REALITIES INC / CREX FAQ

Can you provide the ChartMill fundamental rating for CREATIVE REALITIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to CREX.


What is the valuation status for CREX stock?

ChartMill assigns a valuation rating of 4 / 10 to CREATIVE REALITIES INC (CREX). This can be considered as Fairly Valued.


What is the profitability of CREX stock?

CREATIVE REALITIES INC (CREX) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CREX stock?

The Earnings per Share (EPS) of CREATIVE REALITIES INC (CREX) is expected to grow by 131.68% in the next year.